RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Worldwide Clinical Trials, Inc. (Worldwide), a full-service, midsize, global contract research organization (CRO), announced today that Clare Wallis has joined as senior vice president to lead its growing team of oncology experts. Under Wallis’ guidance, the global team will work in partnership with oncology sponsors to support their clinical development objectives from early phase studies to large global registrational programs.
Wallis joins Worldwide’s deep bench of seasoned oncology experts, bringing 23 years of experience developing highly effective, global operational and clinical teams that can navigate the nuances of designing and executing a successful, tailored clinical trial. With a rich knowledge of global delivery strategies across all phases, Wallis has helped sponsors execute clinical trials in gene therapy, immuno-oncology and novel targeted therapies, among others. Prior to joining Worldwide, she served as vice president of project management, feasibility and advocacy at Synteract, US (recently acquired by Syneos Health), and held several roles with increasing responsibility at Chiltern, ICON, Orion CRO and Covance.
“This work is personal for me,” said Wallis. “Like many on the Worldwide team and across the globe, I’ve experienced the impact that cancer can have on individuals and families. The opportunity to lead a dedicated team that is passionate about oncology research is inspiring. We stand ready to tackle the most complex trials and achieve our shared goal of bringing new options and potentially breakthrough treatments for cancer patients.”
Over the last decade, this has become critical as oncology research has become highly competitive. with the volume of oncology drugs in late-stage development up more than 60%. Simultaneously, the complexity of trials has increased 20%. This combination results in a high-stakes environment that requires sponsors to reduce development risk with a custom approach for the best chance of commercializing their drug.
“To overcome the growing complexities of clinical trials, sponsors need a nimble team of experts who can advise them on not only the ingredients for a successful trial but also what will make their trial successful,” said Peter Benton, president and chief operating officer, Worldwide Clinical Trials. “Clare has extensive experience bringing together global experts to ensure that trials rise to their unique challenges. Her highly consultative and collaborative philosophy mirrors Worldwide’s adaptive approach to helping biopharma and biotech sponsors overcome hurdles for conclusive studies – no matter how complex.”
Learn about Clare Wallis and Worldwide’s growing team of oncology experts. who are out to improve the CRO experience. And, if you are interested in joining a passionate and collaborative team that is valued and supported by company leadership, committed to operational excellence, and open to invention and innovation, Worldwide is hiring.
About Worldwide Clinical Trials
Worldwide Clinical Trials employs more than 1,900 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia, and Asia. Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval and real-world evidence, we provide world-class, full-service drug development services.
With infrastructure and talent spanning 60 countries, we execute predictable, successful studies with operational excellence across a range of therapeutic areas, including central nervous system, cardiovascular, metabolic, general medicine, oncology and rare diseases. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO. For more information, visit http://www.worldwide.com.